New Delhi: Drug firm Lupin said it has launched its pain relieving Hydrocodone Bitartrate and Acetaminophen tablets in the American market.
The company has launched Hydrocodone Bitartrate and Acetaminophen tablets USP in the strengths of 5mg/325 mg, 7.5 mg/325 mg and 10mg/325 mg after receiving approval from the US Food and Drug Administration (USFDA), Lupin said in a BSE filing.
The company’s product is a generic version of Allergan Sales LLCs Norco tablets in the same strengths and is indicated for the relief of moderate to moderately severe pain, it added.
As per IMS MAT June 2017 data, Hydrocodone Bitartrate and Acetaminophen tablets had annual sales of around USD 710 million.
Ruby Khatun joined Medical Dialogue as Reporter in 2016. She covers all the business news in different categories. She also covers all the updates in Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a post graduate from Jamia Hamdard. She can be contacted at firstname.lastname@example.org Contact no. 011-43720751